ArticleJournal of medicinal chemistry2023

Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors.

G Leslie Burnett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.